{"denoms":[{"counts":[{"groupId":"BG000","value":"204"}],"units":"Participants"}],"groups":[{"description":"All patients were administered the following drugs;\n\n1. Fludarabine 30mg/m2 intravenously daily at the same time over 30 min on days -7,-6,-5,-4, and -3\n2. Melphalan 140mg/m2 IV on day -2\n3. Stem cell infusion on day 0\n4. Campath 20mg IV on day -7,-6,-5,-4, and -3","id":"BG000","title":"T-cell Depleted Allogeneic Stem Cell Transplantation"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"12.0","value":"51.0"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"93"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"111"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"}]}